TickerFacts.

Compare

Rhythm Pharmaceuticals, Inc. vs Maravai Lifesciences Holdings, Inc. vs Stoke Therapeutics, Inc. vs Lifevantage Corp

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearRhythm Pharmaceuticals, Inc.
RYTM		Maravai Lifesciences Holdings, Inc.
MRVI		Stoke Therapeutics, Inc.
STOK		Lifevantage Corp
LFVN
Year ended2025-12-312025-12-312025-12-312026-06-30
Revenue$189.76M$185.74M$184.42M$182.59M
Revenue growth (YoY)+45.8%-28.3%+404.5%-20.1%
Gross margin89.7% (computed)18.3%n/a77.6%
Operating margin-101.2%-115.9%-11.2%3.3%
Net margin-103.6%-70.4%-3.7%2.8%
Net income-$196.54M-$130.77M-$6.88M$5.07M
EPS (Diluted)-$3.11-$0.90-$0.12$0.40
Operating cash flow-$115.67M-$57.57M$45.59M$10.24M
Free cash flow-$116.63M-$70.72M$44.91M$6.67M
Cash & equivalents$54.30M$216.89M$84.22Mn/a
Total assets$480.20M$770.58M$418.43M$62.11M
Total liabilities$210.17M$397.87M$65.98M$28.52M
Shareholders' equity$139.07M$212.38M$352.46M$33.59M
Return on year-end equity-141.3%-61.6%-2.0%15.1%
Shares outstanding67.21Mn/a58.92M12.52M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearRhythm Pharmaceuticals, Inc.Maravai Lifesciences Holdings, Inc.Stoke Therapeutics, Inc.Lifevantage Corp
Latest$189.76M
Ended 2025-12-31		$185.74M
Ended 2025-12-31		$184.42M
Ended 2025-12-31		$182.59M
Ended 2026-06-30
1 year earlier$130.13M
Ended 2024-12-31		$259.19M
Ended 2024-12-31		$36.55M
Ended 2024-12-31		$228.53M
Ended 2025-06-30
2 years earlier$77.43M
Ended 2023-12-31		$288.94M
Ended 2023-12-31		$8.78M
Ended 2023-12-31		$200.16M
Ended 2024-06-30
3 years earlier$23.64M
Ended 2022-12-31		$883.00M
Ended 2022-12-31		$12.40M
Ended 2022-12-31		$213.40M
Ended 2023-06-30
4 years earlier$3.15M
Ended 2021-12-31		$799.24M
Ended 2021-12-31		n/a$206.36M
Ended 2022-06-30